cmAngio® vs Vista OS
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if you are a radiologist or imaging center seeking to leverage existing mammography screenings for early cardiovascular risk assessment in women. This tool allows for the detection and quantification of Breast Arterial Calcifications (BAC) from both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, providing valuable insights into a patient's potential for heart disease and stroke without additional radiation or procedures.
View cmAngio® →Choose Vista OS if…
Choose Vista OS if you are a hospital or imaging center looking to enhance the efficiency and consistency of cardiac MRI acquisitions, particularly if you utilize GE and Siemens MRI scanners. This AI-powered software automates and simplifies the cardiac MRI process, including scan planning and localization, which can improve productivity and ensure high-quality imaging. It's ideal for facilities aiming to optimize their MRI workflow and provide consistent, high-quality cardiac imaging.
View Vista OS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Vista OS |
|---|---|---|
| Pricing | Paid, out-of-pocket | Unknown |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Vista AI Scan installs on customer-provided hardware and communicates directly with GE and Siemens MRI scanners. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngio emphasizes ease of implementation and integration, stating quick installation (less than an hour) and compatibility with any DICOM-compliant viewer. It also highlights a user-friendly solution built on physician feedback. Vista OS, while automating cardiac MRI acquisition, does not provide specific details on its user interface or ease of use beyond integration with existing MRI scanners and PACS.
Clinical Value
cmAngio®cmAngio provides objective, clinical insights from routine mammograms by detecting, quantifying, and contextualizing Breast Arterial Calcifications (BAC), which are linked to cardiovascular disease. It offers age-based context and prevalence information, enhancing its clinical utility for early risk assessment without additional procedures or radiation. Vista OS focuses on enhancing consistency and productivity in cardiac MRI acquisition, which is valuable, but cmAngio offers a novel diagnostic insight from an existing screening.
Pricing & Value
cmAngio®cmAngio provides clear pricing details, stating an out-of-pocket cost of $75-$90, which can be paid with HSA or FSA funds. Vista OS's website lacks specific pricing information, making it difficult for potential customers to assess its value proposition. This transparency gives cmAngio an advantage in this dimension.
Enterprise Readiness
cmAngio®cmAngio is cloud-based, HIPAA-compliant, and DICOM-compliant, with FHIR JSON data export, indicating strong interoperability and adherence to healthcare standards. It also mentions a 4-week implementation process and deployment at over 400 clinical sites. Vista OS integrates with GE and Siemens MRI scanners and common PACS, but lacks the detailed enterprise-level compliance and deployment information provided by cmAngio.
Innovation
cmAngio®cmAngio is highlighted as the 'first and only FDA-cleared AI solution' for detecting, quantifying, and contextualizing Breast Arterial Calcifications on mammograms, effectively turning a mammogram into a '2-for-1 exam' for both breast cancer and cardiovascular risk assessment. This represents a significant innovative application of AI to an existing diagnostic procedure. Vista OS's automation of cardiac MRI acquisition is also innovative, but cmAngio's approach to leveraging existing data for a new diagnostic purpose stands out.
Support & Docs
cmAngio®cmAngio explicitly lists comprehensive support components including implementation resources, educational materials, hands-on support, technical documentation, and useful guides/FAQs. Vista OS does not provide specific details regarding its support and documentation, making cmAngio the clearer winner in this aspect.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Vista OS |
|---|---|---|
| Tool Name | cmAngiou00ae | Vista OS |
| Company | CureMetrix | Vista AI, Inc. |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared, AI-powered software that automates and simplifies cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging. |
| Primary Categories | Cardiology AI, OB/GYN AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Key Feature 1 | AI-based detection of Breast Arterial Calcifications (BAC) | AI-powered automated cardiac MRI acquisition |
| Key Feature 2 | Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | Automated scan planning & localization in 30 seconds |
| Key Feature 3 | Provides visualization of BAC location on a scorecard | Parameter tuning for optimal image settings |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Vista OS.